Transforming potential of Src family kinases is limited by the cholesterol-enriched membrane microdomain
- PMID: 19822664
- PMCID: PMC2786866
- DOI: 10.1128/MCB.00941-09
Transforming potential of Src family kinases is limited by the cholesterol-enriched membrane microdomain
Abstract
The upregulation of Src family kinases (SFKs) has been implicated in cancer progression, but the molecular mechanisms regulating their transforming potentials remain unclear. Here we show that the transforming ability of all SFK members is suppressed by being distributed to the cholesterol-enriched membrane microdomain. All SFKs could induce cell transformation when overexpressed in C-terminal Src kinase (Csk)-deficient fibroblasts. However, their transforming abilities varied depending on their affinity for the microdomain. c-Src and Blk, with a weak affinity for the microdomain due to a single myristate modification at the N terminus, could efficiently induce cell transformation, whereas SFKs with both myristate and palmitate modifications were preferentially distributed to the microdomain and required higher doses of protein expression to induce transformation. In contrast, disruption of the microdomain by depleting cholesterol could induce a robust transformation in Csk-deficient fibroblasts in which only a limited amount of activated SFKs was expressed. Conversely, the addition of cholesterol or recruitment of activated SFKs to the microdomain via a transmembrane adaptor, Cbp/PAG1, efficiently suppressed SFK-induced cell transformation. These findings suggest that the membrane microdomain spatially limits the transforming potential of SFKs by sequestering them away from the transforming pathways.
Figures
Similar articles
-
Roles of raft-anchored adaptor Cbp/PAG1 in spatial regulation of c-Src kinase.PLoS One. 2014 Mar 27;9(3):e93470. doi: 10.1371/journal.pone.0093470. eCollection 2014. PLoS One. 2014. PMID: 24675741 Free PMC article.
-
Cholesterol and lipid microdomains stabilize the postsynapse at the neuromuscular junction.EMBO J. 2006 Sep 6;25(17):4050-60. doi: 10.1038/sj.emboj.7601288. Epub 2006 Aug 24. EMBO J. 2006. PMID: 16932745 Free PMC article.
-
The ups and downs of SRC regulation: tumor suppression by Cbp.Cancer Cell. 2008 Jun;13(6):469-71. doi: 10.1016/j.ccr.2008.05.011. Cancer Cell. 2008. PMID: 18538730
-
C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.Growth Factors. 2005 Sep;23(3):233-44. doi: 10.1080/08977190500178877. Growth Factors. 2005. PMID: 16243715 Review.
-
Regulation of the SRC family kinases by Csk.Int J Biol Sci. 2012;8(10):1385-97. doi: 10.7150/ijbs.5141. Epub 2012 Nov 1. Int J Biol Sci. 2012. PMID: 23139636 Free PMC article. Review.
Cited by
-
c-Src promotes tumor progression through downregulation of microRNA-129-1-3p.Cancer Sci. 2020 Feb;111(2):418-428. doi: 10.1111/cas.14269. Epub 2020 Jan 17. Cancer Sci. 2020. PMID: 31799727 Free PMC article.
-
Pretreatment high cholesterol and low neutrophils predict complete pathological response after neoadjuvant short‑course radiotherapy followed by chemotherapy and immunotherapy in locally advanced rectal cancer.Oncol Lett. 2023 Jun 7;26(1):319. doi: 10.3892/ol.2023.13905. eCollection 2023 Jul. Oncol Lett. 2023. PMID: 37332340 Free PMC article.
-
Lipid rafts control P2X3 receptor distribution and function in trigeminal sensory neurons of a transgenic migraine mouse model.Mol Pain. 2011 Sep 29;7:77. doi: 10.1186/1744-8069-7-77. Mol Pain. 2011. PMID: 21958474 Free PMC article.
-
Diacylglycerol kinase α promotes 3D cancer cell growth and limits drug sensitivity through functional interaction with Src.Oncotarget. 2014 Oct 30;5(20):9710-26. doi: 10.18632/oncotarget.2344. Oncotarget. 2014. PMID: 25339152 Free PMC article.
-
Role of Membrane Cholesterol Levels in Activation of Lyn upon Cell Detachment.Int J Mol Sci. 2018 Jun 19;19(6):1811. doi: 10.3390/ijms19061811. Int J Mol Sci. 2018. PMID: 29921831 Free PMC article. Review.
References
-
- Brdicka, T., M. Imrich, P. Angelisova, N. Brdickova, O. Horvath, J. Spicka, I. Hilgert, P. Luskova, P. Draber, P. Novak, N. Engels, J. Wienands, L. Simeoni, J. Osterreicher, E. Aguado, M. Malissen, B. Schraven, and V. Horejsi. 2002. Non-T cell activation linker (NTAL): a transmembrane adaptor protein involved in immunoreceptor signaling. J. Exp. Med. 196:1617-1626. - PMC - PubMed
-
- Brdicka, T., D. Pavlistova, A. Leo, E. Bruyns, V. Korinek, P. Angelisova, J. Scherer, A. Shevchenko, I. Hilgert, J. Cerny, K. Drbal, Y. Kuramitsu, B. Kornacker, V. Horejsi, and B. Schraven. 2000. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation. J. Exp. Med. 191:1591-1604. - PMC - PubMed
-
- Brown, M., and J. Cooper. 1996. Regulation, substrates and functions of src. Biochim. Biophys. Acta 1287:121-149. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous